Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Ghko B 2025 Jul 09, 16:00

Stock market today: Nasdaq rallied to new highs as Nvidia hits $4T valuation

Stocks Indices
Ghko B 2025 Jul 09, 16:00

Datadog (DDOG) Joins S&P 500: What’s the Datadog stock price target in 2025?

Stocks Indices
Frances Wang 2025 Jul 08, 16:00

DJT Stock News: Trump Media Plans to Bring Blue Chip Crypto ETF to Market

Stocks ETFs
Ghko B 2025 Jul 08, 16:00

Trump crypto portfolio: TRUMP meme coin, MELANIA coin, ETH, Chainlink

AAPL
Tommy Yap 2025 Jul 08, 16:00

Morning Note: RBNZ Holds; Yen Falls on Tariffs; Copper Surges on Tariffs

Morning Note Central Banks Forex Commodities
Tommy Yap 2025 Jul 07, 16:00

Morning Note: RBA Holds Rates; Trump Tariffs Hit; Tesla Dips on Musk News

Morning Note Stocks Central Banks
Frances Wang 2025 Jul 06, 16:00

Stock market today: Dow, S&P 500, Nasdaq futures fall, Sensex, Nifty update

Stocks Indices
Frances Wang 2025 Jul 06, 16:00

Lumber Stocks to Watch: SSD stock, UFPI stock, HD stock

Stocks

Info

Spread

0.05

Spread (%)

0.7133 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1140268800

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

2.93

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Trustpilot